Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04603001
Title Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Loxo Oncology, Inc.
Indications

hematologic cancer

Therapies

LY3410738

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST